Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use.


Visscher R., Yalçın N., Bayraktar I., Bayraktar-Ekincioglu A.

European journal of hospital pharmacy : science and practice, cilt.31, sa.2, ss.180-182, 2023 (SCI-Expanded) identifier identifier